In Brief: Cardiovascular & Renal Drugs Advisory Committee
Executive Summary
Cardiovascular & Renal Drugs Advisory Committee: Feb. 27-28 meeting agenda is shuffled. Committee will consider Medco's Bidil for chronic congestive heart failure followed by SmithKline Beecham's Coreg for treatment of moderate chronic CHF on Feb. 27. On the morning of Feb. 28, Roche will present data on Posicor for treatment of hypertension and angina. In the afternoon, the committee will review Cor's Integrilin as an adjunct to aspirin or heparin in patients undergoing PTCA ("The Pink Sheet" Jan. 20, T&G-1)...